Establishment of prenatal diagnosis for β-thalassaemia

Beta-thalassaemia constitutes a major health burden on the limited health resources of India and prenatal diagnosis is seen as an important preventive measure to reduce the burden of the disease. Prenatal diagnosis has been offered to 99 women in 112 pregnancies by fetal DNA analysis, using a PCR-based Amplification Refractory Mutation System (ARMS) for the common and uncommon Indian mutations. Restriction fragment length polymorphism (RFLP) for the beta-globin gene was used when the mutation remained unidentified in one of the parents or to complement the ARMS result. In 53 cases the fetus tested had beta-thalassaemia trait (betaTT) (47.3%), 22 were normal (19.6%) and 31 had thalassaemia major (27.6%). In five cases (4.5%), a definitive report could not be given due to maternal contamination. In one case (0.9%), there was a misdiagnosis. Pitfalls encountered in the diagnosis were maternal contamination and occasional non-amplification of the primers. Having established a regional centre for the prenatal diagnosis for thalassaemia, the screening programmes will be enlarged both to identify carriers and prevent the birth of further homozygous children, even during the first pregnancy

Biology · Control (management · Developing country · Economic growth · Economics · Fetus · Obstetrics · Pregnancy · Prenatal diagnosis · Child Nutrition and Water Access · Computer Science · Hemoglobinopathies and Related Disorders · Medicine · Artificial Intelligence · Genetics

• Ethnicity, equity, and access to genetic services—the UK perspective

  Open Access•Pritti Mehta, A K Saggar et al.•Annals of Human Biology•2005

  Add to list

• Carrier screening for beta-thalassemia in the Maldives

  Open Access•Fazeela Waheed, Colleen Fisher et al.•Journal of Community Genetics•2016

  Add to list